233 related articles for article (PubMed ID: 17191107)
1. Gene expression profile study in CFTR mutated bronchial cell lines.
Gambardella S; Biancolella M; D'Apice MR; Amati F; Sangiuolo F; Farcomeni A; Chillemi G; Bueno S; Desideri A; Novelli G
Clin Exp Med; 2006 Dec; 6(4):157-65. PubMed ID: 17191107
[TBL] [Abstract][Full Text] [Related]
2. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.
Hamosh A; Trapnell BC; Zeitlin PL; Montrose-Rafizadeh C; Rosenstein BJ; Crystal RG; Cutting GR
J Clin Invest; 1991 Dec; 88(6):1880-5. PubMed ID: 1721624
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.
Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J
Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850
[TBL] [Abstract][Full Text] [Related]
4. Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting.
Bruscia E; Sangiuolo F; Sinibaldi P; Goncz KK; Novelli G; Gruenert DC
Gene Ther; 2002 Jun; 9(11):683-5. PubMed ID: 12032687
[TBL] [Abstract][Full Text] [Related]
5. Suitability of oligonucleotide-mediated cystic fibrosis gene repair in airway epithelial cells.
de Semir D; Nadal M; González JR; Larriba S; Avinyó A; Nunes V; Casals T; Estivill X; Aran JM
J Gene Med; 2003 Jul; 5(7):625-39. PubMed ID: 12825202
[TBL] [Abstract][Full Text] [Related]
6. Abnormal spatial diffusion of Ca2+ in F508del-CFTR airway epithelial cells.
Antigny F; Norez C; Cantereau A; Becq F; Vandebrouck C
Respir Res; 2008 Oct; 9(1):70. PubMed ID: 18973672
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effect of miglustat in bronchial epithelial cells.
Dechecchi MC; Nicolis E; Norez C; Bezzerri V; Borgatti M; Mancini I; Rizzotti P; Ribeiro CM; Gambari R; Becq F; Cabrini G
J Cyst Fibros; 2008 Nov; 7(6):555-65. PubMed ID: 18815075
[TBL] [Abstract][Full Text] [Related]
8. Nonsense mutation R1162X of the cystic fibrosis transmembrane conductance regulator gene does not reduce messenger RNA expression in nasal epithelial tissue.
Rolfini R; Cabrini G
J Clin Invest; 1993 Dec; 92(6):2683-7. PubMed ID: 7504691
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis patients with the 3272-26A-->G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane.
Beck S; Penque D; Garcia S; Gomes A; Farinha C; Mata L; Gulbenkian S; Gil-Ferreira K; Duarte A; Pacheco P; Barreto C; Lopes B; Cavaco J; Lavinha J; Amaral MD
Hum Mutat; 1999; 14(2):133-44. PubMed ID: 10425036
[TBL] [Abstract][Full Text] [Related]
11. Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model.
Haston CK; Cory S; Lafontaine L; Dorion G; Hallett MT
Physiol Genomics; 2006 Apr; 25(2):336-45. PubMed ID: 16614460
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
13. Altered terminal glycosylation and the pathophysiology of CF lung disease.
Rhim AD; Stoykova LI; Trindade AJ; Glick MC; Scanlin TF
J Cyst Fibros; 2004 Aug; 3 Suppl 2():95-6. PubMed ID: 15463936
[TBL] [Abstract][Full Text] [Related]
14. The study of cystic fibrosis transmembrane conductance regulator gene mutations in a group of patients from Romania.
Frenţescu L; Brownsell E; Hinks J; Malone G; Shaw H; Budişan L; Bulman M; Schwarz M; Pop L; Filip M; Tomescu E; Moşescu S; Popa I; Benga G
J Cyst Fibros; 2008 Sep; 7(5):423-8. PubMed ID: 18467194
[TBL] [Abstract][Full Text] [Related]
15. [Cystic fibrosis: molecular update and clinical implications].
Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
[TBL] [Abstract][Full Text] [Related]
16. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.
Liu X; Jiang Q; Mansfield SG; Puttaraju M; Zhang Y; Zhou W; Cohn JA; Garcia-Blanco MA; Mitchell LG; Engelhardt JF
Nat Biotechnol; 2002 Jan; 20(1):47-52. PubMed ID: 11753361
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
Salvatore F; Scudiero O; Castaldo G
Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
[TBL] [Abstract][Full Text] [Related]
18. Modifier genes in cystic fibrosis lung disease.
Merlo CA; Boyle MP
J Lab Clin Med; 2003 Apr; 141(4):237-41. PubMed ID: 12677168
[TBL] [Abstract][Full Text] [Related]
19. Maintaining low Ca2+ level in the endoplasmic reticulum restores abnormal endogenous F508del-CFTR trafficking in airway epithelial cells.
Norez C; Antigny F; Becq F; Vandebrouck C
Traffic; 2006 May; 7(5):562-73. PubMed ID: 16643279
[TBL] [Abstract][Full Text] [Related]
20. Regulated expression of the human CFTR gene in epithelial cells.
Ye L; Chan S; Chow YH; Tsui LC; Hu J
Mol Ther; 2001 May; 3(5 Pt 1):723-33. PubMed ID: 11356077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
